株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心血管インターベンション:バスキュラーアクセスサイト閉塞製品

Interventional Cardiology: Vascular Access Site Closure Products

発行 Datamonitor Healthcare 商品コード 858343
出版日 ページ情報 英文 88 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
心血管インターベンション:バスキュラーアクセスサイト閉塞製品 Interventional Cardiology: Vascular Access Site Closure Products
出版日: 2018年10月26日 ページ情報: 英文 88 Pages
概要

当レポートでは、世界のバスキュラーアクセスサイト閉塞製品市場について調査し、心血管疾患の概要、市場成長の促進要因・抑制要因、セグメント別の製品分析、技術動向、競合戦略、および主要企業などについてまとめています。

第1章 心血管疾患の概要

  • 急性冠症候群
  • 高血圧症
  • 心不全
  • 末梢血管疾患
  • 脳血管疾患
  • 参考資料

第2章 バスキュラーアクセスサイト閉塞製品

  • 血管閉塞製品の種類
  • 血管閉塞装置
  • 止血圧迫装置
  • その他の止血製品
  • 参考資料

第3章 バスキュラーアクセスサイト閉塞製品市場

  • 世界市場の考察
  • 世界の競合企業
  • 市場予測
  • 市場予測:その他 (RoW)
  • 一次調査
目次
Product Code: #MDT18016

Overview

Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the markets for vascular access site closure products, which include active and passive vascular closure devices, as well as other hemostatic products (eg dressings, manual compression assist devices, radial compression bands).

The global market for vascular access site closure products is anticipated to see moderate, single-digit growth throughout the forecast period covered by this analysis (2017-22). Growth in unit sales is being driven by the increasing prevalence of cardiovascular disease, which is the leading cause of death globally, responsible for over 17 million deaths annually. Primary research querying interventional cardiologists regarding device preferences and utilization was leveraged in the formulation of this report's forecasts and analyses. Global product sales are projected to expand at a compound annual growth rate (CAGR) of 6.5% during the 2017-22 forecast, increasing from approximately $748.8m in 2017 to an estimated $1,023.8m in 2022.

TABLE OF CONTENTS

Executive Summary

  • i. Cardiovascular diseases overview
  • ii. Global vascular access site closure products market
    • a. Market drivers and limiters
    • b. Device segment insights
    • c. Technology trends
    • d. Market leaders
    • e. Competitive strategies
    • f. Emerging competition
  • iii. Methodology
  • Exhibit ES-1: Vascular access site closure products, global market forecast, 2017-22
  • Exhibit ES-2: Global vascular access site closure products market, share by country/region, 2017
  • Exhibit ES-3: Drivers and limiters of growth - vascular access site closure products

1. Cardiovascular Diseases Overview

  • 1.1. Acute coronary syndrome
    • 1.1.1. Atherosclerosis
    • 1.1.2. Angina pectoris
    • 1.1.3. Myocardial infarction
    • 1.1.4. Diagnosis and treatment
  • 1.2. Hypertension
  • 1.3. Heart failure
  • 1.4. Peripheral vascular disease
    • 1.4.1. Critical limb ischemia
    • 1.4.2. Aneurysm
    • 1.4.3. Deep vein thrombosis/pulmonary embolism
    • 1.4.4. Diagnosis and treatment
  • 1.5. Cerebrovascular disease
    • 1.5.1. Diagnosis and treatment
  • 1.6. Bibliography
  • Exhibit 1-1: Estimated deaths attributable to cardiovascular disease, select countries, 2016
  • Exhibit 1-2: Top 10 countries with the highest CVD death rates for males and females
  • Exhibit 1-3: Estimated incident cases for acute coronary syndrome, select continents, 2017
  • Exhibit 1-4: Estimated deaths attributable to ischemic heart disease, select countries, 2016
  • Exhibit 1-5: Age-standardized incidence (per 100,000) of angina pectoris, select regions, 1990 and 2010
  • Exhibit 1-6: Clinical classification of acute myocardial infarction
  • Exhibit 1-7: Age-standardized incidence (per 100,000) of acute myocardial infarction, select regions, 1990 and 2010
  • Exhibit 1-8: Estimated prevalent cases of hypertension, select countries, 2017
  • Exhibit 1-9: Estimated deaths attributable to hypertensive heart disease, select countries, 2016
  • Exhibit 1-10: Estimated incidence of acute decompensated heart failure, select countries, 2017
  • Exhibit 1-11: Estimated prevalent cases of chronic heart failure, select countries, 2017
  • Exhibit 1-12: Estimated prevalence of peripheral artery disease, select countries, 2016
  • Exhibit 1-13: Estimated incident cases of DVT, select countries, 2017
  • Exhibit 1-14: Estimated incident cases of PE, select countries, 2017
  • Exhibit 1-15: Estimated incident cases of ischemic stroke, select countries, 2017
  • Exhibit 1-16: Estimated incident cases of hemorrhagic stroke, select countries, 2017
  • Exhibit 1-17: Estimated prevalent cases of ischemic stroke, select countries, 2017
  • Exhibit 1-18: Estimated prevalent cases of hemorrhagic stroke, select countries, 2017

2. Vascular Access Site Closure Products

  • 2.1. Types of vascular closure products
    • 2.1.1. Advantages and disadvantages
  • 2.2. Vascular closure devices
  • 2.3. Hemostatic compressive devices
  • 2.4. Other hemostatic products
  • 2.5. Bibliography
  • Exhibit 2-1: Advantages and disadvantages of vascular closure devices
  • Exhibit 2-2: Selected vascular closure devices
  • Exhibit 2-3: Selected hemostatic compressive devices
  • Exhibit 2-4: Selected hemostatic products for the management of vascular access sites

3. Vascular Access Site Closure Products Market

  • 3.1. Global market insights
    • 3.1.1. Market value
    • 3.1.2. Technology trends
    • 3.1.3. Market drivers and limiters
    • 3.1.4. Vascular access site closure products overview
    • 3.1.5. Market leaders
    • 3.1.6. Competitive strategies
    • 3.1.7. Emerging competition
  • 3.2. Global competitors
  • 3.3. Market forecast
    • 3.3.1. Market forecast: US
    • 3.3.2. Market forecast: five major EU markets
    • 3.3.3. Market forecast: Japan
    • 3.3.4. Market forecast: Rest of the world
  • 3.4. Primary research
  • 3.5. Bibliography
  • Exhibit 3-1: Vascular access site closure products, global market forecast, 2017-22
  • Exhibit 3-2: Global vascular access site closure products market, share by country/region, 2017
  • Exhibit 3-3: Global vascular access site closure product sales, combined market forecast ($m), by country/region, 2017-22
  • Exhibit 3-4: Drivers and limiters of market growth - vascular access site closure products
  • Exhibit 3-5: Vascular access site closure products, share by product type, for 2017 and 2022
  • Exhibit 3-6: Global vascular access site closure products market, share by supplier, 2017
  • Exhibit 3-7: US minimally invasive interventional cardiology, procedure volumes forecast (000s), 2017-22
  • Exhibit 3-8: US vascular access site closure products, estimated procedure volumes forecast (000s), 2017-22
  • Exhibit 3-9: US vascular access site closure product sales, estimated market forecast ($m), 2017-22
  • Exhibit 3-10: US vascular access site closure products market, share by supplier, 2017
  • Exhibit 3-11: 5EU minimally invasive interventional cardiology, procedure volumes forecast (000s), 2017-22
  • Exhibit 3-12: 5EU vascular access site closure products, estimated procedure volumes forecast (000s), 2017-22
  • Exhibit 3-13: 5EU vascular access site closure product sales, estimated market forecast ($m), 2017-22
  • Exhibit 3-14: 5EU vascular access site closure products market, share by supplier, 2017
  • Exhibit 3-15: Japanese minimally invasive interventional cardiology, procedure volumes forecast (000s), 2017-22
  • Exhibit 3-16: Japanese vascular access site closure products, estimated procedure volumes forecast (000s), 2017-22
  • Exhibit 3-17: Japanese vascular access site closure product sales, estimated market forecast ($m), 2017-22
  • Exhibit 3-18: Japanese vascular access site closure products market, share by supplier, 2017
  • Exhibit 3-19: RoW vascular access site closure product sales, estimated market forecast ($m), 2017-22
  • Exhibit 3-20: RoW vascular access site closure products market, share by supplier, 2017
  • Exhibit 3-21: Reported average number of interventional cardiology procedures performed monthly - survey results
  • Exhibit 3-22: Reported average utilization of vascular access site closure products, by region - survey results
  • Exhibit 3-23: Reported average utilization of vascular access sites, by region - survey results

Appendix: Company Listing

Back to Top